Eupraxia Pharmaceuticals Inc (EPRX.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||
| Depreciation Amortization | 155 | 92 | 68 |
| Accounts receivable | 104 | -154 | -281 |
| Other Working Capital | 369 | 807 | -477 |
| Other Operating Activity | -4,586 | -6,854 | -3,523 |
| Operating Cash Flow | $-3,959 | $-6,109 | $-4,213 |
| Cash Flows From Investing Activities | |||
| PPE Investments | -7 | -104 | -250 |
| Other Investing Activity | -1,443 | 0 | 0 |
| Investing Cash Flow | $-1,451 | $-104 | $-250 |
| Cash Flows From Financing Activities | |||
| Change In Short Term Borrowing | 3,445 | 0 | 374 |
| Debt Issued | 2,308 | 2,680 | 0 |
| Debt Repayment | -89 | -5 | -6 |
| Common Stock Issued | N/A | 0 | 7,193 |
| Other Financing Activity | 0 | 1,213 | -33 |
| Financing Cash Flow | $5,664 | $3,888 | $7,528 |
| Beginning Cash Position | 630 | 2,930 | 108 |
| End Cash Position | 885 | 605 | 3,173 |
| Net Cash Flow | $255 | $-2,325 | $3,065 |
| Free Cash Flow | |||
| Operating Cash Flow | -3,959 | -6,109 | -4,213 |
| Capital Expenditure | -7 | -104 | -250 |
| Free Cash Flow | -3,966 | -6,213 | -4,463 |